US Patent 11623958 Single chain variable fragment CD3 binding proteins
Patent 11623958 was granted and assigned to Harpoon Therapeutics on April, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11623958 Single chain variable fragment CD3 binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.